Log In
Print this Print this

CEP-9722, CK-102

  Manage Alerts
Collapse Summary General Information
Company Teva Pharmaceutical Industries Ltd.
DescriptionPoly(ADP-ribose) polymerase (PARP) inhibitor
Molecular Target Poly(ADP-ribose) polymerase (PARP)
Mechanism of ActionPoly(ADP-ribose) polymerase (PARP) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I/II
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
PartnerCheckpoint Therapeutics Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today